Study at a glance
How was vitamin D tested in nerve cells that handle serotonin?
Researchers exposed a rat nerve-cell line to active vitamin D and measured genes involved in handling serotonin, a chemical messenger. They also measured serotonin in the liquid around the cells. The experiment used several concentrations and growth conditions. It did not test ordinary vitamin D3 supplements, mood or brain function in people.
How did active vitamin D affect genes involved in handling serotonin?
At one tested concentration, there were fewer RNA instructions for making a protein that transports serotonin and an enzyme that breaks it down. Other concentrations did not clearly reproduce those reductions, and another breakdown-related gene did not significantly respond. Genes involved in serotonin production increased strongly under particular growth conditions. RNA changes do not directly measure protein amounts, transport or enzyme activity.
Did the amount of serotonin around the cells change?
More serotonin accumulated in the surrounding liquid under some conditions. This went beyond measuring genes, but involved only three independent samples in those experiments. The increase could reflect several processes, including production, release, uptake into cells or breakdown. The study did not separate their contributions. Different experiments also used different comparisons, so their numerical results cannot be combined into one time sequence.
Do these cell findings show that supplements improve mood?
Growth conditions strongly affected the response. A separately engineered human tumour-cell model showed a different pattern and did not represent ordinary human brain cells. The study did not prove that the vitamin D receptor was necessary for every proposed step or measure working brain connections. These findings suggest a possible link in the cells’ chemistry, but do not establish improved mood, an antidepressant effect, an ideal supplement dose or a blood vitamin D target.
Read the full article below ↓A 2018 cell experiment found that active vitamin D changed several serotonin-related gene transcripts and increased serotonin measured in the surrounding culture medium. The strongest responses depended on the concentration and growth conditions. These findings help define a possible molecular connection between vitamin D and serotonin, but they do not show improved mood, altered human brain circuits or an effective supplement regimen. For the shorter account, see Vitamin D and Serotonin-Related Genes in Rat Neuronal Cells: Study Summary.
This is a VD3FL analysis of the published research, not the original paper. The principal article and all six figures were reviewed for this account. Findings are reported as research observations, not treatment recommendations.
The question behind the experiment
Serotonin is a chemical messenger, but the amount available outside a cell depends on several processes. Cells can make it, release it, take it back up and break it down. Sabir and colleagues investigated whether active vitamin D influenced genes involved in more than one of these steps. This was a laboratory question about cellular responses, rather than a trial in people with depression.
The distinction matters when moving from the broader topic of Vitamin D and Mood to a particular experiment. A plausible biochemical connection can justify further research without establishing that changing one nutrient will change an emotional state. The useful contribution here is the combination of transcript measurements with a measurement of serotonin in culture medium.
Which cells and which form of vitamin D?
The main model was RN46A-B14, a rat embryonic medullary raphe cell line with serotonergic characteristics. The line had originally been developed through a brain-derived neurotrophic factor manipulation. It is a reproducible experimental model, but it is neither an intact rat brain nor a sample of ordinary human neurons. No behavioural or neural-circuit outcome was collected.
Cells received 1, 10 or 100 nanomolar calcitriol, the active hormone 1,25-dihydroxyvitamin D, with an ethanol vehicle comparison. Calcitriol placed directly in a culture dish is different from cholecalciferol taken by mouth. The study bypassed the absorption, transport and activation steps encountered in a person. Its concentrations cannot be converted into a recommended daily intake or a desirable blood 25-hydroxyvitamin D level.
For comparison, the researchers also examined U87 human glioblastoma/astrocytoma cells after adding a human vitamin D receptor expression construct. The rat and human models differed in species, cell origin and receptor manipulation. A different response between them therefore cannot isolate a universal difference between neurons and other brain cells. Vitamin D and Brain provides the wider tissue context; the present study addresses only these selected cell systems.
What the gene measurements can show
Quantitative polymerase chain reaction measured messenger RNA after 24 hours. Messenger RNA is an intermediate in the production of proteins. Results were normalised to the reference gene GAPDH. The central targets were SERT, which encodes a serotonin transporter; MAO-A, which is involved in serotonin breakdown; and TPH enzymes, which participate in serotonin synthesis.
The relationship between a transcript and its eventual protein product is explained in Vitamin D and Gene Expression. Lower SERT messenger RNA does not by itself show slower serotonin transport, and lower MAO-A messenger RNA does not directly measure less enzyme activity. Those functional steps would need their own assays. The paper did not measure transporter activity, MAO-A protein or synaptic signalling.
CYP24A1, a well-established vitamin D-responsive gene, served as a positive response control. Its induction showed that the cells could mount a transcriptional response under the experimental conditions. It did not prove that every serotonin-related change resulted from direct receptor binding at that particular gene.
Transcript results were selective
In the rat cells, 10 nanomolar calcitriol was associated with 59% lower SERT messenger RNA and 51% lower MAO-A messenger RNA than vehicle. The reported P values were .0001 and .015 respectively, with nine biological replicates in these experiments. MAO-B did not show a significant response. The lower and higher calcitriol concentrations did not significantly reproduce the SERT and MAO-A reductions.
The authors used analysis of variance with Dunnett comparisons for the main transcript experiments, after initially examining t-tests. The figures show standard deviations. Variable results, several targets and concentration comparisons mean that a single favourable concentration should not be read as a precisely established biological optimum. Nonsignificant comparisons also do not prove that the true effects at the other concentrations are exactly zero.
The different readouts also address different time windows. A transcript measured after 24 hours and serotonin accumulated over 72 hours are related observations, but they are not simultaneous measurements of a single biochemical event. A rise in the medium cannot establish precisely when synthesis changed or when uptake became slower. Following protein abundance and transport over the same intervals would make that proposed sequence easier to test.
Relative changes require care as well. A 33-fold increase describes a ratio to a particular control transcript level; it does not mean that the cells produced 33 times as much usable serotonin. Likewise, the reported reductions in SERT and MAO-A transcripts are not percentages of transport or degradation prevented. Keeping those quantities separate preserves the interesting result without giving it a functional magnitude that was never measured.
In receptor-transfected U87 cells, SERT and MAO-A did not show the same significant reductions. MAO-B messenger RNA was about 25% lower at 10 nanomolar, with 27 biological replicates and P=.005. This differing pattern is informative about the particular experimental models, while remaining insufficient to establish a rule for normal human brain cell types.
Culture conditions changed the response
The study compared three media. A serum-free neuronal medium produced a more neuron-like appearance and slower growth; a high-glucose medium containing serum produced a faster-growing, more fibroblast-like appearance. The photographs illustrated these differences but did not provide a quantitative proof of neuronal differentiation.
In the serum-free neuronal conditions, TPH2 messenger RNA increased markedly after 10 nanomolar calcitriol. One experiment showed approximately 32-fold induction; a separate experiment reported about 33-fold induction, with 30 biological replicates and P<.0001. TPH1 also increased, by about 28-fold in the reported experiment with nine biological replicates. These are changes relative to the corresponding control conditions, not absolute quantities of enzyme or serotonin.
The strong TPH2 response was not reproduced in the same way across the other media. That dependence is central to the result. It illustrates why Vitamin D Response concerns the biological setting as well as the presence of a molecule. Changing growth conditions can change the interpretation of the same nominal calcitriol exposure.
Serotonin increased in the surrounding medium
The researchers used an enzyme-linked immunosorbent assay to measure serotonin accumulated outside the cells. This added an outcome beyond messenger RNA. In the 72-hour concentration experiment, the 10 nanomolar condition produced about 2.9 times the control concentration and the 100 nanomolar condition about twice the control concentration. The small decrease at 1 nanomolar was not statistically significant.
A separate 10 nanomolar time-course experiment reported approximately 1.7-fold, 1.6-fold and twofold increases at 24, 48 and 72 hours. These experiments used different normalisation, so the 2.9-fold and twofold results should not be merged into a single trajectory or treated as a reporting contradiction. Each answers a somewhat different comparison.
The serotonin experiments had three biological replicates; technical duplicate or triplicate assay readings were averaged within them. Repeating a measurement from the same biological sample improves measurement reliability but does not turn three independent samples into nine. The small biological sample leaves uncertainty about how stable the effect would be in further experiments.
Extracellular accumulation is a net result. It can reflect synthesis, release, uptake, breakdown and the number or condition of cells. The assay did not disentangle those contributions. It therefore supports a change in culture-medium serotonin, while leaving the proposed transport and degradation mechanisms incompletely tested.
Where the receptor explanation remains a hypothesis
The vitamin D receptor is a reasonable candidate for linking calcitriol exposure to gene regulation. Vitamin D Receptors explains that receptor framework, while Vitamin D Signalling Pathways places transcription within the wider signalling process. In this study, however, possible regulatory DNA sites were identified using computational searches and earlier binding evidence from other cell systems.
The experiment did not remove the receptor in the rat cells or directly demonstrate its binding at each proposed regulatory site. Consequently, receptor involvement is a plausible interpretation, but direct binding and receptor necessity were not established for the complete serotonin pathway described in the paper. The distinction is developed in Why VDR Presence Is Not the Same as Vitamin D Response.
The final synapse illustration in the paper is a proposed model. It is not an observed recording of a working synapse, and it supplies no measurement of electrical activity, connectivity or mood-related behaviour. Its arrows are useful as questions for subsequent experiments, provided that they are not reported as additional observed results.
What this contributes to mood research
The study brings several potentially related observations together: selected transcripts involved in serotonin handling changed, synthesis-related transcripts increased under particular culture conditions, and serotonin accumulated in the medium. That combination is more informative than receptor presence alone. It offers a testable account of how calcitriol might influence a serotonin-producing cell.
The missing steps are substantial. Protein abundance and activity, transport, release, intact neural networks and behavioural outcomes were not established. No person received a supplement, and no clinical mood score was collected. A comparison with the mechanism of an antidepressant therefore remains an analogy, not evidence that vitamin D reproduces that medicine’s clinical effects.
The article title uses the word “optimal”. Within this analysis, that refers only to the pattern observed among the tested culture conditions. It does not identify an optimal nutritional dose, blood target or treatment strategy. A larger response in a dish is not automatically a better health outcome.
Conclusion
Sabir and colleagues demonstrated a condition-dependent response to calcitriol in a rat serotonergic cell model. The main evidence is selective messenger-RNA change alongside increased serotonin in culture medium. The study supports further investigation of a molecular connection, while leaving direct transporter and enzyme function, receptor necessity, human brain signalling and clinical mood effects unresolved.
The authors reported NIH support and declared no competing interests. This account uses original explanatory prose and source attribution; it does not reproduce the paper’s figures.
Scientific sources
Sabir MS, Haussler MR, Mallick S, et al. Optimal vitamin D spurs serotonin: 1,25-dihydroxyvitamin D represses serotonin reuptake transport (SERT) and degradation (MAO-A) gene expression in cultured rat serotonergic neuronal cell lines. Genes & Nutrition. 2018;13:19. DOI 10.1186/s12263-018-0605-7; PMID 30008960.
Related reading
Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis
Despite intensive research, the aetiology of multiple sclerosis (MS) remains unknown.
Original paper ↗Read more →Deep clinical, genetic, and serum biomarker profiling indicates glial and neuronal pathology in primary brain calcification
Primary brain calcification (primary familial brain calcification in inherited cases) is an often-genetic condition characterized by symmetrical brain calcifications and neuropsychiatric symptoms.
Original paper ↗Read more →Hypertension in obese children is associated with vitamin D deficiency and serotonin dysregulation
The aim of this paper is to determine the associations between vitamin D, serotonin, and blood pressure in obese children.
Original paper ↗Read more →Neuronal Biomarkers and Micronutrient Status in Adults with Mild Cognitive Impairment
However, studies that comprehensively examined the associations between micronutrients, neuronal markers, and cognitive impairment are scarce.
Original paper ↗Read more →Neuroprotective effects of vitamin D on high fat diet: and palmitic acid-induced enteric neuronal loss in mice
The role of vitamin D in obesity and diabetes is debated.
Original paper ↗Read more →Optimal vitamin D spurs serotonin: 1,25-dihydroxyvitamin D represses serotonin reuptake transport (SERT) and degradation (MAO-A) gene expression in cultured rat serotonergic neuronal cell lines
However, other enzymes and transporters in the pathway of tryptophan metabolism had yet to be examined with respect to the actions of vitamin D.
Original paper ↗Read more →Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis
The levels of NF-H and UCHL1 were higher in the group of VitDd compared to VitDn.
Original paper ↗Read more →Vitamin D receptor is present on the neuronal plasma membrane and is co-localized with amyloid precursor protein, ADAM10 or Nicastrin
The localization of VDR on neuronal membranes and its co-localization with target proteins were investigated with cell surface staining followed by immunofluorescence labelling.
Original paper ↗Read more →Vitamins D and E Stimulate the PI3K-AKT Signalling Pathway in Insulin-Resistant SK-N-SH Neuronal Cells
This study investigated the effects of vitamins D and E on an insulin-resistant model and hypothesized that this treatment would reverse the effects of Alzheimer’s disease (AD) and improves insulin signalling.
Original paper ↗Read more →Vitamin D and Serotonin-Related Genes in Rat Neuronal Cells: Study Summary
A concise account of vitamin D and serotonin-related gene findings in rat neuronal cells, explaining what the experiment can and cannot show about people.
Read more →Viral infection of human neurons triggers strain-specific differences in host neuronal and viral transcriptomes
Infection with herpes simplex virus 1 (HSV-1) occurs in over half the global population, causing recurrent orofacial and/or genital lesions.
Original paper ↗Read more →VDR Regulates BNP Promoting Neurite Growth and Survival of Cochlear Spiral Ganglion Neurons through cGMP-PKG Signaling Pathway
This study primarily aimed to explore the expression and function of BNP in the rat’s inner ear and elucidate its regulatory mechanism.
Original paper ↗Read more →The Role of Vitamin D in Parkinson’s Disease: Evidence from Serum Concentrations, Supplementation, and VDR Gene Polymorphisms
Background/aim: Vitamin D (VitD) has been implicated in neuroprotection, yet its role in Parkinson’s disease (PD) remains unclear.
Original paper ↗Read more →Vitamin D and omega-3 fatty acids attenuate MSG-induced neurodegeneration by modulating tau pathology, neuroinflammation, and VDR expression in rats
Fifty male Sprague Dawley rats were randomly allocated to a control, an MSG, and three treatment groups that received MSG and either Vit D or N-3 PUFA supplements in combinations or alone for 4 weeks.
Original paper ↗Read more →Mitochondrial Translocation of Vitamin D Receptor Is Mediated by the Permeability Transition Pore in Human Keratinocyte Cell Line
We then adopted different pharmacological and silencing approaches with the aim of hampering PTP function, either affecting PTP opening or abating the expression of the complex member StAR.
Original paper ↗Read more →Non‐genomic rewiring of vitamin D receptor to p53 as a key to Alzheimer's disease
Thus, we investigated the role of VDR in AD using postmortem human brains, APP/PS1 mice, and cell cultures.
Original paper ↗Read more →Parkinson’s disease-associated alterations in DNA methylation and hydroxymethylation in human brain
Epigenetic mechanisms mediate interactions between aging, genetics, and environmental factors in sporadic Parkinson’s disease (PD).
Original paper ↗Read more →Upregulation of Placental Vitamin D Receptor Expression in Gestational Diabetes Is Not Directly Related to Vitamin D Concentration
This study aimed to examine the expression of the vitamin D receptor in the placenta of patients with gestational diabetes mellitus and healthy women.
Original paper ↗Read more →Relevance of Vitamin D Receptor Target Genes for Monitoring the Vitamin D Responsiveness of Primary Human Cells
Vitamin D3 has transcriptome: and genome-wide effects and activates, via the binding of its metabolite 1α,25-dihydroxyvitamin D3 to the transcription factor vitamin D receptor (VDR), several hundred target genes.
Original paper ↗Read more →Polymorphisms in Vitamin D Receptor Genes in Association with Childhood Autism Spectrum Disorder
This case-control study aimed to determine the association of single-nucleotide polymorphisms (SNPs) rs731276 (TaqI), rs1568820 (Cdx2), rs1544410 (BsmI), and rs2228570 (FokI) in the vitamin D receptor (VDR) gene with susceptibility of childhood ASD and severity of the disease.
Original paper ↗Read more →Vitamin D and Mood
Explore how vitamin D participates in mood regulation through brain signalling, neurochemical balance, immune pathways, and whole-system physiological coordination.
Read more →Original sources
Optimal vitamin D spurs serotonin: 1,25-dihydroxyvitamin D represses serotonin reuptake transport (SERT) and degradation (MAO-A) gene expression in cultured rat serotonergic neuronal cell lines
Published in Genes & Nutrition (2018).
Publication details
Sabir MS, Haussler MR, Mallick S, et al. Optimal vitamin D spurs serotonin: 1,25-dihydroxyvitamin D represses serotonin reuptake transport (SERT) and degradation (MAO-A) gene expression in cultured rat serotonergic neuronal cell lines. Genes & Nutrition. 2018;13:19. DOI 10.1186/s12263-018-0605-7; PMID 30008960.